Skip to main content

Post-IPO Equity Health Care Companies

Explore 434 health care startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
434
Total Funding
$3.1B
Avg Funding
$125.3M
Cities
18

Export 434 Post-IPO Equity Health Care Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Redwood City, United States
$132.0M
raised

Jasper Therapeutics is a biotechnology company that develops novel antibody therapies for stem cell transplants.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$200.0M
raised

Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Englewood Cliffs, United States
$11.7M
raised

Silo Pharma is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$50.0M
raised

Cue Biopharma is a developer of a productive platform for the treatment of cancer and autoimmune disease.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boca Raton, United States
$8.5M
raised

Grid AI delivers innovative energy management solutions for homes, businesses, and industrial campuses.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Fort Lauderdale, United States
$1.0M
raised

Splash Beverage Group is a manufacturer of non-alcoholic and flavored beverages that offer delicious, natural, and healthy drinks.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$15.0M
raised

Elicio Therapeutics is a pharmaceutical research company that develops an immuno-tumor vaccine to treat cancer.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Palo Alto, United States
$1.0B
raised

BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Fort Lee, United States
$100.0M
raised

Nuvectis Pharma is a biopharmaceutical company intended to develop novel targeted therapeutics for the treatment of cancer.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$4.4M
raised

Medicenna is a clinical stage, privately held, immuno-oncology company.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United States
$3.5M
raised

Decoy Therapeutics is a biotech company that design the next generation of peptide conjugate therapies to protect and expand patient lives.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Leiden, The Netherlands
$59.2M
raised

ProQR Therapeutics is a biotech company focused on developments of drugs to treat genetic disorders.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$1.4M
raised

BioNxt Solutions mission is to develop and commercialize next-generation pharmaceuticals.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$805.0M
raised

Definium Therapeutics provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Piscataway, United States
$226.0M
raised

Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
$6.1M
raised

Zelluna Immunotherapy is a privately owned Norwegian biopharmaceutical company.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$57.5M
raised

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$57.5M
raised

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$57.5M
raised

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$57.5M
raised

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Reykjavík, Iceland
$165.0M
raised

Alvotech is a biotechnology company that specializes in making biosimilars to create biologic medicines.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Brisbane, Australia
$3.5M
raised

Microba Life Sciences is a precision microbiome science company powering medical innovation to transform human health.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Richmond Hill, Canada
$2.1M
raised

Cheelcare develops robotic mobility devices and accessories for people with disabilities.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$75.0M
raised

Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Charlottesville, United States
$32.0M
raised

Adial Pharmaceuticals develops prescription medications for addiction and related disorders.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 26 to 50 of 434 companies

Ready to Connect with Post-IPO Equity Health Care Startups?

Get verified founder emails, funding details, and company data for 434 post-ipo equity health care companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

434 Health Care Post-IPO Equity Startups (November 2026) — Page 2 | VCBacked